Today, NCCS joined colleagues in the cancer community in submitting comments to the National Institutes of Health (NIH) on the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research. We commend the National Institutes of Health (NIH) for taking this step to reduce duplication ...

In late December 2014, NCCS joined colleagues in the Cancer Leadership Council in submitting comments to the Department of Health and Human Services (HHS) regarding the proposed rule on notice of benefit and payment parameters for 2016. Many cancer survivors have purchased qualified health plans (QHPs) through the health insurance ...

Last week, NCCS joined colleagues in the Cancer Leadership Council (CLC) in submitting comments to the National Association of Insurance Commissioners (NAIC) on the Health Benefit Plan Network Access and Adequacy Model Act. The groups collectively commend the NAIC Regulatory Framework (B) Task Force for including provisions within the act ...

Last week, NCCS submitted comments to the U.S. Food and Drug Administration (FDA) regarding the series of patient-focused drug development meetings that have been convened and the list of disease topic meetings scheduled for 2016-2017. In 2013, FDA convened a patient-focused drug development meeting related to lung cancer and has ...

The Food and Drug Administration Safety and Innovation Act (FDASIA) authorized a patient-focused drug development program, and in the years since enactment, the U.S. Food and Drug Administration (FDA) has implemented certain initiatives of the patient-focused program. In recent weeks, FDA has requested feedback regarding patient-focused activities to date and ...

Click here to view all of NCCS' policy comments. Recently, NCCS submitted comments to the Center for Medicare and Medicaid Innovation on its proposed Oncology Care Model (OCM), an episode-based payment model that emphasizes care planning and coordination and cancer care system transformation.   The OCM represents an important step forward ...

Recently, NCCS joined colleagues in the Cancer Leadership Council (CLC) in submitting comments to the Centers for Medicare and Medicaid Services (CMS) on the 2015 Physician Fee Schedule, which governs payments to physicians for services provided to Medicare patients. NCCS and the CLC have applauded efforts by CMS to strengthen ...

The National Coalition for Cancer Survivorship (NCCS) commends the Food and Drug Administration (FDA) for taking critical steps to ensure that the promise of personalized cancer medicine is realized and that cancer patients can rest assured that they are receiving treatments consistent with their diagnoses. Today, FDA notified Congress that ...

The United States House of Representatives' Energy and Commerce Committee released a Call to Action and announced the 21st Century Cures initiative to analyze the discovery, development, and delivery of cures and propose policy solutions. Over the course of the initiative, which officially launched on June 1, 2014, the committee ...

Why should patients care about how physicians are paid? Because the way we as a country, and Medicare as the largest payer, compensate physicians directly affects the care patients receive. Our current system is not sustainable for physicians, patients, or taxpayers. The manner in which Medicare currently reimburses for cancer ...